Clinical trial
Penetration of Ertapenem Into Bone
NCT00392028 · HaEmek Medical Center, Israel, Other · Withdrawn
Key facts
| NCT number | NCT00392028 |
|---|---|
| Title | Penetration of Ertapenem Into Bone |
| Official title | Penetration of Ertapenem Into Bone in Patients With Diabetes Mellitus or Peripheral Vascular Diseases Who Underwent Bellow Knee Amputation |
| Lead sponsor | HaEmek Medical Center, Israel, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Amputation |
| Intervention type | Drug |
| Interventions | ertapenem |
| Enrollment | 12 |
| Start date | Nov 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Oct 25, 2006 |
| Last update posted | Jul 13, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: